Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
221876-21-7	N-(4-Methyl-3-nitrophenyl)-3-(trifluoromethyl)benzamide CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)[N+](=O)[O-]	C₁₅H₁₁F₃N₂O₃	324.25	97%	Click to inquire
2220162-06-9	NMDAR antagonist 1 C1CC2=NC3=C(CN2C1C(=O)NCCC4=CC=C(C=C4)O)C=C(C=C3)Br	C₂₀H₂₀BRN₃O₂	414.3	98%	Click to inquire
2226517-76-4	Sgc-gak-1 COC1=CC(=CC(=C1OC)OC)NC2=C3C=C(C=CC3=NC=C2)Br	C₁₈H₁₇BRN₂O₃	389.2	98%	Click to inquire
2226521-65-7	(E)-2-cyano-3-(5-(1-cyclohexyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2-yl)furan-2-yl)-N,N-dimethylacrylamide CN(C)C(=O)C(=CC1=CC=C(O1)C2=NC3=CN=C4C(=C3N2C5CCCCC5)C=CN4)C#N	C₂₄H₂₄N₆O₂	428.5	98%	Click to inquire
2226735-55-1	(S)-6-(4-(5-(3,5-difluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbonyl)piperidin-1-yl)pyrimidine-4-carbonitrile C1CN(CCC1C(=O)N2C(CC=N2)C3=CC(=CC(=C3)F)F)C4=NC=NC(=C4)C#N	C₂₀H₁₈F₂N₆O	396.4	98%	Click to inquire
2227425-05-8	(s)-3-Chloro-7-(2-(hydroxymethyl)morpholino)-2-methyl-5-(trifluoromethyl)-1h-pyrrolo[3,2-b]pyridine-6-carbonitrile CC1=C(C2=C(N1)C(=C(C(=N2)C(F)(F)F)C#N)N3CCOC(C3)CO)Cl	C₁₅H₁₄ClF₃N₄O₂	374.74	98%	Click to inquire
2229036-62-6	2-(4-(4-((5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)piperidin-1-yl)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)acetamide CC1=CC(=C(C=C1C2CCN(CC2)CC(=O)NCCNC3=CC=CC4=C3C(=O)N(C4=O)C5CCC(=O)NC5=O)OC(C)C)NC6=NC=C(C(=N6)NC7=CC=CC=C7S(=O)(=O)C(C)C)Cl	C₄₅H₅₂ClN₉O₈S	914.5	98%	Click to inquire
2229039-45-4	6-[(2-amino-4-hydroxy-5-methylphenyl)diazenyl]-3,4-dihydro-1H-quinolin-2-one CC1=CC(=C(C=C1O)N)N=NC2=CC3=C(C=C2)NC(=O)CC3	C₁₆H₁₆N₄O₂	296.32	98%	Click to inquire
2230820-11-6	7-Methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(oxan-4-yl)purin-8-one CC1=CC2=NC=NN2C=C1NC3=NC=C4C(=N3)N(C(=O)N4C)C5CCOCC5	C₁₈H₂₀N₈O₂	380.4	98%	Click to inquire
2230821-27-7	Gefitinib-based PROTAC 3 CC1=C(SC=N1)C2=CC=C(C=C2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)CCOCCOCCCCCOC4=C(C=C5C(=C4)C(=NC=N5)NC6=CC(=C(C=C6)F)Cl)OC)O	C₄₇H₅₇ClFN₇O₈S	934.5	96%	Click to inquire

N-(4-Methyl-3-nitrophenyl)-3-(trifluoromethyl)benzamide

N-(4-Methyl-3-nitrophenyl)-3-trifluoromethylbenzamide

C₁₅H₁₁F₃N₂O₃ 324.25

NMDAR antagonist 1

NMDAR antagonist 1

C₂₀H₂₀BRN₃O₂ 414.3

C₁₈H₁₇BRN₂O₃ 389.2

(E)-2-cyano-3-(5-(1-cyclohexyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2-yl)furan-2-yl)-N,N-dimethylacrylamide

C₂₄H₂₄N₆O₂ 428.5

(S)-6-(4-(5-(3,5-difluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbonyl)piperidin-1-yl)pyrimidine-4-carbonitrile

C₂₀H₁₈F₂N₆O 396.4

(s)-3-Chloro-7-(2-(hydroxymethyl)morpholino)-2-methyl-5-(trifluoromethyl)-1h-pyrrolo[3,2-b]pyridine-6-carbonitrile

C₁₅H₁₄ClF₃N₄O₂ 374.74

2-(4-(4-((5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-5-isopropoxy-2-methylphenyl)piperidin-1-yl)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)acetamide

C₄₅H₅₂ClN₉O₈S 914.5

6-[(2-amino-4-hydroxy-5-methylphenyl)diazenyl]-3,4-dihydro-1H-quinolin-2-one

C₁₆H₁₆N₄O₂ 296.32

7-Methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(oxan-4-yl)purin-8-one

C₁₈H₂₀N₈O₂ 380.4

Gefitinib-based PROTAC 3

Gefitinib-based PROTAC 3

C₄₇H₅₇ClFN₇O₈S 934.5

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15637) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号